A Maryland-based unit of AstraZeneca will share in an $811 million U.S. government order of components and tests of a swine-flu vaccine for stockpiles to protect health-care workers along with children and other vulnerable people.
The orders were placed with GlaxoSmithKline Plc, Novartis AG, CSL Ltd., MedImmune Inc. — which AstraZeneca …